Prostate Cancer - Results from #21840

Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer? - Abstract November 11, 2013

Partnership status affects the association between gastrointestinal symptoms and quality of life after radiation therapy for prostate cancer - Abstract November 11, 2013

Dosimetric impact of Acuros XB dose calculation algorithm in prostate cancer treatment using RapidArc - Abstract November 11, 2013

Mayo study customizing treatments for deadly prostate cancer with tumor genomics November 11, 2013

Whole prostate D(90) and V(100): A dose-response analysis of 2000 consecutive 125I monotherapy patients - Abstract November 11, 2013

The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: Evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group - Abstract November 11, 2013

Translating clinical trials to clinical practice: Outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials - Abstract November 11, 2013

Strontium-89 for prostate cancer with bone metastases: The potential of cancer control and improvement of overall survival - Abstract November 11, 2013

Predicting utility scores for prostate cancer: Mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS) - Abstract November 11, 2013

Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: A paired validating cohort study using template prostate mapping biopsies as the reference standard - Abstract November 11, 2013

Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve sparing radical prostatectomy: A randomized, controlled trial - Abstract November 11, 2013

Modeling grade progression in an active surveillance study - Abstract November 9, 2013

Revisiting the central gland anatomy via MRI: Does the central gland extend below the level of verumontanum? - Abstract November 9, 2013

A case of septic shock caused by extended spectrum β-lactamase producing Escherichia coli after transrectal prostate biopsy, successfully treated by endotoxin adsorption therapy - Abstract November 8, 2013

Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer - Abstract November 8, 2013

The cost implications of prostate cancer screening in the Medicare population - Abstract November 8, 2013

What do Canadian uro-oncologists believe patients should know about androgen deprivation therapy? - Abstract November 8, 2013

Survival in patients with metastatic spinal cord compression from prostate cancer is associated with the number of extra-spinal organs involved - Abstract November 8, 2013

Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer - Abstract November 8, 2013

Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: A phase I study - Abstract November 8, 2013

Page 1093 of 1435